UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                    FORM 10-Q

           (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                For the quarterly period ended September 30, 2003
                                               ------------------

                         Commission File Number 0-19294

                                       OR

( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
                                   ACT OF 1934

                        For the transition period from  to


                              REHABCARE GROUP, INC.
                              ---------------------
             (Exact name of Registrant as specified in its charter)

          Delaware                                    51-0265872
- ------------------------------         ---------------------------------------
(State or other jurisdiction of         (I.R.S. Employer Identification Number)
incorporation or organization)


             7733 Forsyth Boulevard, Suite 1700, St. Louis, MO 63105
             -------------------------------------------------------
              (Address of principal executive offices and zip code)

                                  314-863-7422
               --------------------------------------------------
              (Registrant's telephone number, including area code)

Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the Registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.

                       Yes    X                 No
                            -----                  -----

Indicate by check mark whether the Registrant is an accelerated filer (as
defined in Rule 12b-2 of the Act).  Yes   X                 No
                                        -----                  -----

Indicate the number of shares outstanding of the Registrant's common stock, as
of the latest practicable date.


                Class                           Outstanding at November 11, 2003
- --------------------------------------          --------------------------------
Common Stock, par value $.01 per share                    16,119,128



                                    1 of 26


                              REHABCARE GROUP, INC.

                                      Index



Part I. - Financial Information

   Item 1. - Condensed Consolidated Financial Statements

      Condensed consolidated balance sheets,
        September 30, 2003 (unaudited) and December 31, 2002               3

      Condensed consolidated statements of earnings for the three months
        and nine months ended September 30, 2003 and 2002 (unaudited)      4

      Condensed consolidated statements of cash flows for the
        nine months ended September 30, 2003 and 2002 (unaudited)          5

      Condensed consolidated statements of comprehensive earnings for
        three months and nine months ended September 30, 2003 and 2002
        (unaudited)                                                        6

      Notes to condensed consolidated financial statements (unaudited)     7

   Item 2. - Management's Discussion and Analysis of Financial
      Condition and Results of Operations                                 14

   Item 3. - Quantitative and Qualitative Disclosures about Market Risks  23

   Item 4. - Controls and Procedures                                      23

Part II. - Other Information                                              24

   Item 1. - Legal Proceedings                                            24

   Item 6. - Exhibits and Reports on Form 8-K                             25

   Signatures                                                             26


                                    2 of 26




PART 1. - FINANCIAL INFORMATION
Item 1. - Condensed Consolidated Financial Statements


                              REHABCARE GROUP, INC.
                      Condensed Consolidated Balance Sheets
             (dollars in thousands, except share and per share data)


                                                     September 30, December 31,
                                                         2003          2002
                                                         ----          ----
                  Assets                              (unaudited)
                  ------
Current assets:
                                                             
    Cash and cash equivalents                         $ 22,420     $  9,580
    Marketable securities, available-for-sale            5,008            4
    Accounts receivable, net of allowance for doubtful
      accounts of $5,773 and $5,181, respectively       90,550       87,221
    Income taxes receivable                              1,856        2,497
    Deferred tax assets                                  5,274        2,529
    Other current assets                                 3,758        3,625
                                                       -------      -------
      Total current assets                             128,866      105,456
Marketable securities, trading                           3,398        4,252
Equipment and leasehold improvements, net               18,403       19,844
Excess cost over net assets acquired, net              101,685      101,685
Other                                                    3,598        4,293
                                                       -------      -------
      Total assets                                    $255,950     $235,530
                                                       =======      =======


         Liabilities and Stockholders' Equity
         ------------------------------------
Current liabilities:
    Accounts payable                                  $  1,752     $  1,959
    Accrued salaries and wages                          30,529       28,579
    Accrued expenses                                     9,830        7,072
                                                       -------      -------
      Total current liabilities                         42,111       37,610
Deferred compensation and other long-term
   liabilities                                           3,417        4,266
Deferred tax liabilities                                 7,220        5,040
                                                       -------      -------
      Total liabilities                                 52,748       46,916
                                                       -------      -------

Stockholders' equity:
   Preferred stock, $.10 par value, authorized
      10,000,000 shares, none issued and outstanding        --           --
    Common stock, $.01 par value; authorized 60,000,000
      shares, issued 20,122,026 shares and 19,846,416
      shares as of September 30, 2003 and December 31,
      2002, respectively                                   201          198
    Additional paid-in capital                         114,428      111,671
    Retained earnings                                  143,276      131,452
    Less common stock held in treasury at cost,
      4,002,898 shares as of September 30, 2003 and
      December 31, 2002                                (54,704)     (54,704)
    Accumulated other comprehensive earnings                 1           (3)
                                                        ------      -------
      Total stockholders' equity                       203,202      188,614
                                                       -------      -------
                                                      $255,950     $235,530
                                                       =======      =======


      See accompanying notes to condensed consolidated financial statements.

                                   3 of 26




                              REHABCARE GROUP, INC.
                  Condensed Consolidated Statements of Earnings
                  (amounts in thousands, except per share data)
                                   (Unaudited)


                                     Three Months Ended      Nine Months Ended
                                        September 30,           September 30,
                                      2003       2002         2003       2002
                                      ----       ----         ----       ----

                                                           
Operating revenues                 $134,962   $142,690     $409,847    $421,755
Costs and expenses:
   Operating expenses               103,581    103,909      310,486     310,358
   Selling, general & administrative
      Divisions                      15,786     18,576       51,213      56,396
      Corporate                       6,553      6,432       20,288      21,190
   Restructuring charge               1,286         --        1,286          --
   Depreciation and amortization      2,084      2,178        6,429       6,138
                                    -------    -------      -------     -------
     Total costs and expenses       129,290    131,095      389,702     394,082
                                    -------    -------      -------     -------

     Operating earnings               5,672     11,595       20,145      27,673
Interest income                          40         88           83         299
Interest expense                       (184)      (183)        (532)       (508)
Other income (expense)                   10         11          (63)         15
                                     ------    -------      -------     -------
Earnings before income taxes          5,538     11,511       19,633      27,479
Income taxes                          2,215      4,374        7,809      10,442
                                    -------    -------      -------    --------
     Net earnings                  $  3,323   $  7,137    $  11,824   $  17,037
                                    =======    =======     ========    ========

Net earnings per common share:
     Basic                         $   0.21   $   0.43      $  0.74     $  0.99
                                    =======    =======      =======     =======
     Diluted                       $   0.20   $   0.41      $  0.72     $  0.95
                                    =======    =======      =======     =======
Weighted-average number of common
   shares outstanding:
     Basic                           16,086     16,741       15,962      17,168
                                    =======    =======      =======     =======
     Diluted                         16,540     17,455       16,507      18,002
                                    =======    =======      =======     =======



     See accompanying notes to condensed consolidated financial statements.

                                    4 of 26




                                REHABCARE GROUP, INC.
                 Condensed Consolidated Statements of Cash Flows
                             (dollars in thousands)
                                     (Unaudited)

                                                             Nine Months Ended
                                                               September 30,
                                                             2003       2002
                                                             ----       ----
Cash flows from operating activities:
                                                              
   Net earnings                                          $ 11,824   $ 17,037
   Adjustments to reconcile net earnings to net
     cash provided by operating activities:
        Depreciation and amortization                       6,429      6,138
        Provision for doubtful accounts                     2,704      3,227
        Write-down of investment                               50         --
        Restucturing charge                                   871         --
        Income tax benefit realized on employee
           stock option exercises                             764        565
        Change in assets and liabilities:
           Accounts receivable, net                        (6,033)       667
           Prepaid expenses and other current assets         (133)    (1,353)
           Other assets                                       337        309
           Accounts payable and accrued expenses            1,680     (3,222)
           Accrued salaries and wages                       1,950      1,684
           Deferred compensation                             (703)       337
           Income taxes                                        76      5,562
                                                           ------     ------
               Net cash provided by operating activities   19,816     30,951
                                                           ------     ------

Cash flows from investing activities:
   Additions to equipment and leasehold improvements, net  (4,074)    (7,559)
   Purchase of marketable securities                       (5,288)      (356)
   Proceeds from sale/maturities of marketable securities     996      1,030
   Other, net                                                (606)    (1,267)
                                                           ------     ------
               Net cash used in investing activities       (8,972)    (8,152)
                                                           ------     ------

Cash flows from financing activities:
   Purchase of treasury stock                                  --    (36,947)
   Exercise of stock options                                1,996      1,342
                                                           ------     ------
               Net cash provided by (used in)
                  financing activities                      1,996    (35,605)
                                                           ------     ------
               Net increase (decrease) in cash
                  and cash equivalents                     12,840    (12,806)
Cash and cash equivalents at beginning of period            9,580     18,534
                                                           ------     ------
Cash and cash equivalents at end of period               $ 22,420   $  5,728
                                                           ======     ======



     See accompanying notes to condensed consolidated financial statements.

                                    5 of 26




                              REHABCARE GROUP, INC.
                 Condensed Consolidated Statements of Comprehensive Earnings
                             (dollars in thousands)
                                   (Unaudited)


                                 Three Months Ended         Nine Months Ended
                                    September 30,              September 30,
                                  2003         2002           2003       2002
                                  ----         ----           ----       ----

                                                           
Net earnings                  $  3,323       $  7,137     $  11,824    $ 17,037

Other comprehensive earnings:
    Unrealized holding gains
    (losses) arising during
    period on securities             3            (17)            6         (29)
    Income tax benefit (expense)    (1)             5            (2)          8
                               -------        -------       -------     -------

Comprehensive earnings        $  3,325       $  7,125     $  11,828   $  17,016
                               =======        =======      ========    ========



     See accompanying notes to condensed consolidated financial statements.

                                    6 of 26



REHABCARE GROUP, INC.

              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
              ----------------------------------------------------
              Nine Month Periods Ended September 30, 2003 and 2002
                                   (Unaudited)

Note 1. - Basis of Presentation
- -------------------------------

     The   condensed   consolidated   balance   sheets  and  related   condensed
consolidated  statements of earnings,  cash flows,  and  comprehensive  earnings
contained in this Form 10-Q,  which are  unaudited,  include the accounts of the
Company and its wholly owned subsidiaries. All significant intercompany accounts
and  activity  have  been  eliminated  in  consolidation.   In  the  opinion  of
management,  all entries  necessary for a fair  presentation  of such  financial
statements  have been  included.  The results of operations for the three months
and nine months ended September 30, 2003 are not  necessarily  indicative of the
results to be expected for the fiscal year. Certain prior year amounts have been
reclassified to conform to the current year presentation.

     The  condensed   consolidated  financial  statements  do  not  include  all
information  and footnotes  necessary for a complete  presentation  of financial
position,  results of operations  and cash flows in conformity  with  accounting
principles generally accepted in the United States of America. Reference is made
to the Company's audited consolidated financial statements and the related notes
as of  December  31,  2002 and 2001 and for each of the years in the  three-year
period ended  December 31, 2002,  included in the Annual  Report on Form 10-K on
file with the  Securities  and Exchange  Commission,  which  provide  additional
disclosures and a further description of the Company's accounting policies.


Note 2. - Critical Accounting Policies and Estimates
- ----------------------------------------------------

     The  preparation  of  the  accompanying  condensed  consolidated  financial
statements requires management to make judgments and estimates.  Some accounting
policies  have a  significant  impact on  amounts  reported  in these  financial
statements.  A summary of significant  accounting  policies and a description of
accounting policies that are considered critical may be found in our 2002 Annual
Report  on Form  10-K,  filed on March  14,  2003,  in the  Critical  Accounting
Policies  and  Estimates  section  of "Item  7. -  Management's  Discussion  and
Analysis of Financial Condition and Results of Operations."


Note 3. - Goodwill and Other Identifiable Intangible Assets
- -----------------------------------------------------------

     Statement of Financial Accounting  Standards  (Statement) No. 142 "Goodwill
and Other Intangible Assets" eliminates the requirement to amortize goodwill and
indefinite-lived  intangible  assets,  requiring  instead  that those  assets be
tested for  impairment at least  annually,  and more often when events  indicate
that an  impairment  may exist.  An  impairment  loss must be  recognized if the
carrying  amount of an  intangible  asset is not  recoverable  and its  carrying
amount exceeds its fair value. As required by Statement No. 144, "Accounting for
the Impairment or Disposal of Long-Lived  Assets",  a long-lived  asset shall be
tested for recoverability  whenever a significant adverse change in the business
climate  occurs  that  could  affect  the value of a  long-lived  asset.  Due to
conditions in the healthcare staffing industry, our healthcare staffing division
is  experiencing  declines in operating  revenues and operating  earnings.  As a
result, the Company has performed a test for recoverability under the provisions
of Statement No. 144 and  Statement  No. 142 as of September 30, 2003.  Based on
the  tests  performed,   the  Company  has  determined  that  long-lived  assets
(including goodwill) are not impaired as of September 30, 2003. The Company will
continue  to perform  impairment  tests on a  quarterly  basis  until  events or
circumstance indicate that testing is no longer required.

                                    7 of 26



REHABCARE GROUP, INC.

        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
        ----------------------------------------------------------------


Note 4. - Stock-Based Compensation
- ----------------------------------

     The Company accounts for stock-based employee  compensation plans using the
intrinsic  value  method  under  Accounting  Principles  Board  Opinion  No. 25,
"Accounting  for  Stock  Issued  to  Employees",  and  related  Interpretations.
Accordingly,  stock-based  employee  compensation  cost is not  reflected in net
earnings,  as all stock options  granted  under the plans had an exercise  price
equal to the market value of the  underlying  common stock on the date of grant.
Had  compensation  cost for the Company's  stock-based  compensation  plans been
determined  based on the fair value at the grant  dates for awards  under  those
plans  consistent  with  the  method  of  Statement  No.  123,  "Accounting  for
Stock-Based  Compensation,"  the  Company's  net earnings and earnings per share
would have been reduced to the pro forma amounts indicated below:


                                          Three Months Ended    Nine Months Ended
                                             September 30,         September 30,
                                            2003     2002        2003     2002
                                            ----     ----        ----     ----
                                           (in thousands, except per share data)

                                                            
Net earnings, as reported                  $3,323   $7,137     $11,824  $17,037
Deduct: Total stock-based employee
  compensation expense determined under
  fair value based method for all awards,
  net of related tax effects                  860    1,116       3,041    3,559
                                           ------   ------      ------   ------

Pro forma net earnings                     $2,463   $6,021      $8,783  $13,478
                                           ======   ======      ======  =======

Basic net earnings per share: As reported   $0.21    $0.43       $0.74    $0.99
                                            =====    =====       =====    =====
                              Pro forma     $0.15    $0.36       $0.55    $0.79
                                            =====    =====       =====    =====

Diluted net earnings per share:As reported  $0.20    $0.41       $0.72    $0.95
                                            =====    =====       =====    =====
                               Pro forma    $0.15    $0.34       $0.53    $0.75
                                            =====    =====       =====    =====



Note 5. - Net earnings per share
- --------------------------------

      Basic net earnings per share excludes dilution and is computed by dividing
income available to common stockholders by the weighted average common shares
outstanding for the period. Diluted net earnings per share reflects the
potential dilution that could occur if securities or other contracts to issue
common stock were exercised and converted into common stock or resulted in the
issuance of common stock that then shared in the earnings of the entity (as
calculated utilizing the treasury stock method).

                                    8 of 26




REHABCARE GROUP, INC.

        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
        ----------------------------------------------------------------

The following table sets forth the computation of basic and diluted net earnings
per share:


                                       Three Months Ended      Nine Months Ended
                                          September 30,          September 30,
                                        2003       2002        2003       2002
                                        ----       ----        ----       ----
                                          (in thousands, except per share data)
Numerator:
                                                            
Numerator for basic/diluted net
   earnings per share - net earnings
   available to common stockholders   $ 3,323     $ 7,137    $ 11,824   $ 17,037
                                       ======      ======      ======     ======
Denominator:
Denominator for basic net earnings
   per share - weighted-average
   shares outstanding                  16,086      16,741      15,962     17,168
Effect of dilutive securities:
   Stock options                          454         714         545        834
                                       ------      ------      ------     ------
Denominator for diluted net
   earnings per share - adjusted
   weighted-average shares             16,540      17,455      16,507     18,002
                                       ======      ======      ======     ======

Basic net earnings per share          $  0.21     $  0.43     $  0.74   $   0.99
                                       ======      ======      ======     ======

Diluted net earnings per share        $  0.20     $  0.41     $  0.72   $   0.95
                                       ======      ======      ======     ======


Note 6. - Restructuring Costs
- -----------------------------

     On July 30,  2003,  the  Company  announced  a  comprehensive  multifaceted
restructuring   program   to  return  the   Company   to  growth  and   improved
profitability.  As part of the restructuring  program, the Company eliminated 61
positions in an effort to reduce  corporate  support  functions and better align
corporate   overhead  with  the  operating   divisions.   As  a  result  of  the
restructuring plan, the Company recognized  consolidated pre-tax expense of $1.3
million in the quarter ended  September 30, 2003.  Included in the third quarter
restructuring  charge is $1.1 million of severance and outplacement  charges and
$0.2 million for exit costs related to the closing of five StarMed branches. The
Company  accounts  for  restructuring  costs in  accordance  with  Statement  of
Financial  Accounting  Standards No. 146,  "Accounting  for Cost Associated with
Exit or Disposal  Activities." In accordance with Statement No. 146,  management
committed to the restructuring plan and identified the number of employees to be
terminated and the benefits that those employees would receive upon termination.
Employees  were not  required  to  render  service  in order  to  receive  their
benefits,  and thus a liability was recognized at the date the  termination  was
communicated  to the  employee.  The  severance  payments  and exit  costs  will
continue  beyond 2003 since, in many  instances,  the terminated  employees will
receive their  severance  payments over an extended period of time and long-term
lease payments will be paid over periods after 2003.  These charges  recorded in
the  third  quarter  are  reflected  in the  restructuring  charge  line  on the
accompanying consolidated statements of earnings.


      The following table summarizes the activity with respect to the severance
and exit costs recorded in the third quarter:
      (dollars in thousands)
                                        Severance   Exit Costs     Total
                                        ---------   ----------     -----
                                                          
      Q3 2003 Restructuring charges     $ 1,094       $  192       $ 1,286
      Q3 2003 Cash payments                 415           --           415
                                        -------       ------       -------
      Balance September 30, 2003        $   679       $  192       $   871
                                        =======       ======       =======


                                    9 of 26



REHABCARE GROUP, INC.

        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
        ----------------------------------------------------------------


Note 7. - Industry Segment Information
- --------------------------------------

     The Company operates in two business  segments that are managed  separately
based on fundamental differences in operations:  program management services and
healthcare    staffing   services.    Program   management   includes   hospital
rehabilitation  services (including  inpatient acute  rehabilitation and skilled
nursing units and outpatient  therapy  programs) and contract therapy  programs.
All of the  Company's  services  are provided in the United  States.  Summarized
information about the Company's  operations for the three months and nine months
ended September 30, 2003 and 2002 in each industry segment is as follows:


                              Three Months Ended           Nine Months Ended
                                 September 30,               September 30,
                               2003          2002         2003           2002
                               ----          ----         ----           ----
Operating Revenues from
Unaffiliated Customers                         (in thousands)
- --------------------------
                                                          
   Program management:
     Hospital
     rehabilitation
     services               $  46,503      $ 45,210     $ 138,975     $ 133,788
     Contract therapy          33,607        27,223        97,447        76,245
                            ---------      --------     ---------     ---------
     Program
     management total          80,110        72,433       236,422       210,033
   Healthcare staffing         55,191        70,257       174,501       211,722
                            ---------      --------     ---------     ---------
        Subtotal              135,301       142,690       410,923       421,755
        Less Intercompany
                revenues*        (339)           --        (1,076)           --
                            ---------      --------     ---------     ---------
        Total               $ 134,962      $142,690     $ 409,847     $ 421,755
                            =========      ========     =========     =========


*Intercompany revenues represent sales at market rates from the Company's
healthcare staffing segment to the Company's program management segment.


                             Three Months Ended           Nine Months Ended
                                September 30,               September 30,
                              2003          2002         2003           2002
                              ----          ----         ----           ----
Operating Earnings                             (in thousands)
- --------------------------
                                                          
   Program management:
     Hospital
     rehabilitation
     services               $   8,634      $  8,829     $  23,651     $  23,249
     Contract therapy             913         2,581         4,464         6,236
                            ---------      --------     ---------     ---------
     Program
     management total           9,547        11,410        28,115        29,485
   Healthcare staffing         (2,589)          185        (6,684)       (1,812)
                            ---------      --------     ---------     ---------
        Subtotal                6,958        11,595        21,431        27,673
   Restructuring charge        (1,286)           --        (1,286)           --
                            ----------     --------     ----------    ---------
        Total               $   5,672      $ 11,595     $  20,145     $  27,673
                            =========      ========     =========     =========


                                    10 of 26




REHABCARE GROUP, INC.

        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)



                              Three Months Ended           Nine Months Ended
                                 September 30,               September 30,
                               2003          2002         2003           2002
                               ----          ----         ----           ----
Depreciation and
Amortization                                   (in thousands)
- ----------------
                                                           
   Program management:
     Hospital
     rehabilitation
     services                $   1,252      $  1,436     $   4,024     $   3,982
     Contract therapy              343           296           993           788
                             ---------      --------     ---------     ---------
     Program
     management total            1,595         1,732         5,017         4,770
   Healthcare staffing             489           446         1,412         1,368
                             ---------      --------     ---------     ---------
        Total                $   2,084      $  2,178     $   6,429     $   6,138
                             =========      ========     =========     =========



                              Three Months Ended           Nine Months Ended
                                 September 30,               September 30,
                               2003          2002         2003           2002
                               ----          ----         ----           ----
Capital Expenditures                           (in thousands)
- --------------------
                                                           
  Program management:
     Hospital
     rehabilitation
     services                $     892      $    645     $   1,694     $   4,346
     Contract therapy              659           523         1,289         2,850
                             ---------      --------     ---------     ---------
     Program
     management total            1,551         1,168         2,983         7,196
   Healthcare staffing             126            69         1,091           363
                             ---------      --------     ---------     ---------
        Total                $   1,677      $  1,237     $   4,074     $   7,559
                             =========      ========     =========     =========




                                 Total Assets             Unamortized Goodwill
                                 ------------             --------------------
                                 September 30,               September 30,
                               2003          2002         2003           2002
                               ----          ----         ----           ----
                                               (in thousands)
                                                           
   Program management:
     Hospital
     rehabilitation
     services                $ 128,762      $104,949     $  35,739     $  35,739
     Contract therapy           40,581        31,899        12,990        12,990
                             ---------      --------     ---------     ---------
     Program
     management total          169,343       136,848        48,729        48,729
   Healthcare staffing          86,607        95,723        52,956        52,956
                             ---------      --------     ---------     ---------
        Total                $ 255,950      $232,571     $ 101,685     $ 101,685
                             =========      ========     =========     =========

                                    11 of 26



REHABCARE GROUP, INC.

        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Note 8. - Recent Accounting Pronouncements
- ------------------------------------------

     In June 2002,  the FASB  issued  Statement  No. 146  "Accounting  for Costs
Associated with Exit or Disposal  Activities." This statement nullifies Emerging
Issues Task Force Issue No. 94-3,  "Liability  Recognition for Certain  Employee
Termination  Benefits  and Other  Costs to Exit an Activity  (Including  Certain
Costs Incurred in a  Restructuring)."  This statement  requires that a liability
for a cost associated  with an exit or disposal  activity be recognized when the
liability is incurred rather than the date of an entity's  commitment to an exit
plan.  The  Company  implemented  Statement  No. 146 on  January  1,  2003.  For
information regarding the impact of adoption of Statement No. 146 and the impact
of the restructuring that the Company has undertaken during this quarter,  refer
to Note 6. - Restructuring Costs.

     In November  2002,  the FASB  issued  Interpretation  No. 45,  "Guarantor's
Accounting  and  Disclosure  Requirements  for  Guarantees,  Including  Indirect
Guarantees of Indebtedness of Others,  an  interpretation of FASB Statements No.
5,  57,  and  107  and   rescission  of  FASB   Interpretation   No.  34."  This
interpretation  elaborates on the  disclosures  to be made by a guarantor in its
interim and annual  financial  statements  about its  obligations  under certain
guarantees that it has issued. It also clarifies that a guarantor is required to
recognize,  at the  inception of a guarantee,  a liability for the fair value of
the obligation undertaken in issuing the guarantee.  The initial recognition and
measurement  provisions of this  interpretation  are applicable on a prospective
basis to guarantees issued or modified after December 31, 2002,  irrespective of
the guarantor's fiscal year-end.  The disclosure  requirements are effective for
financial  statements  of interim or annual  periods  ending after  December 15,
2002. As adopted,  this  interpretation  does not have a material  effect on the
Company's  financial position or results of operations other than the additional
disclosure requirements.

     In  December  2002,  the FASB  issued  Statement  No. 148  "Accounting  for
Stock-Based  Compensation  -  Transition  and  Disclosure - an amendment of FASB
Statement No. 123." Statement No. 148 amends Statement No. 123,  "Accounting for
Stock-Based  Compensation," to provide  alternative  methods of transition for a
voluntary  change to the fair value-based  method of accounting for  stock-based
employee  compensation.  In addition,  Statement  No. 148 amends the  disclosure
requirements  of  Statement  No. 123 to require  prominent  disclosures  in both
annual and interim financial  statements about the reported  results.  While the
Company  has not  elected  to adopt fair value  accounting  for its  stock-based
compensation,  it has  complied  with  the  new  disclosure  requirements  under
Statement No. 148. As adopted, this statement does not have a material impact on
the Company's financial position or results of operations.

     In January 2003, the FASB issued  Interpretation No. 46,  "Consolidation of
Variable  Interest  Entities."  This  interpretation  explains  how to  identify
variable  interest  entities  and how an  enterprise  assesses its interest in a
variable  interest  entity to decide  whether to  consolidate  that  entity.  In
October  2003  the  FASB  postponed  the   implementation   date  so  that  this
interpretation  is effective for the first interim or annual period ending after
December 15, 2003 to variable  interest  entities in which the variable interest
was acquired  before  February 1, 2003. The Company does not anticipate that the
adoption of this  interpretation will have any effect on the Company's financial
position or results of operations.

                                    12 of 26



REHABCARE GROUP, INC.

        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
        ----------------------------------------------------------------

     In April 2003, the FASB issued  Statement No. 149,  "Amendment of Statement
133 on Derivative  Instruments and Hedging Activities." Statement No. 149 amends
and clarifies the  accounting  for  derivative  instruments,  including  certain
derivative  instruments embedded in other contracts,  and for hedging activities
under  Statement No. 133,  "Accounting  for Derivative  Instruments  and Hedging
Activities." Statement No. 149 is generally effective for contracts entered into
or modified after June 30, 2003 and for hedging  relationships  designated after
June 30, 2003.  The adoption of Statement No. 149 did not have any effect on the
Company's consolidated financial position or results of operations.

     In May 2003,  the FASB issued  Statement No. 150,  "Accounting  for Certain
Financial  Instruments  with  Characteristics  of both  Liabilities and Equity."
Statement  No. 150 requires  that  certain  financial  instruments,  which under
previous  guidance were  accounted  for as equity,  must now be accounted for as
liabilities.  The financial instruments affected include mandatorily  redeemable
stock,  certain financial  instruments that require or may require the issuer to
buy back some of its shares in  exchange  for cash or other  assets and  certain
obligations  that can be  settled  with  shares of stock.  Statement  No. 150 is
effective for all financial  instruments  entered into or modified after May 31,
2003  and  must be  applied  to the  Company's  existing  financial  instruments
effective  July 1, 2003, the beginning of the first fiscal period after June 15,
2003.  The Company  adopted  Statement No. 150 on June 1, 2003.  The adoption of
this statement did not have any effect on the Company's  consolidated  financial
position or results of operations.

Note 9. - Related Party Transaction
- -----------------------------------

     During the third quarter of 2003,  the Board of Directors  approved and the
Company  entered into a contract with a software  vendor to develop a new public
website  for the  Company.  John H.  Short,  interim  CEO and a director  of our
Company, and Theodore M. Wight, a director of our Company, are also directors of
the  software  vendor  company.  Messrs.  Wight and  Short and their  affiliated
entities own 27.3% and 5.5% of the fully diluted  capitalization of the software
company,  respectively.  The  contract  amount is for  $320,000  and the work is
anticipated to be completed by the second quarter of 2004.

     During the second  quarter of 2003,  the Company  entered into an agreement
with Phase 2 Consulting,  LLC ("Phase 2"). Per the terms of the agreement, Phase
2 will provide the Company with  management,  consulting and advisory  services,
including having John H. Short,  Ph.D.,  the managing  director of Phase 2 and a
member of the Company's Board of Directors, serve as interim President and Chief
Executive  Officer of the Company.  A monthly  consulting fee of $55,000 will be
paid to Phase 2 during the term of the agreement plus  reimbursement of business
expenses.  In addition,  Phase 2 will be entitled to an incentive  fee capped at
$1.3  million  payable  in  cash or  shares  of the  Company's  stock  based  on
predetermined performance standards.



                                    13 of 26



REHABCARE GROUP, INC.

        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
        ----------------------------------------------------------------

     In conjunction  with his  resignation  from his officer  positions with the
Company  during  the  second  quarter  of 2003,  Alan C.  Henderson,  the former
President and Chief  Executive  Officer and currently a director of the Company,
entered into a one-year consulting  arrangement with the Company. The consulting
arrangement continues Mr. Henderson's  then-current monthly compensation and car
allowance of $45,191.54 per month, health and medical benefits, and stock option
vesting  during  the  consulting  period  until  June 3,  2004.  The  consulting
arrangement supersedes a similar level of payments and benefit continuation that
Mr.  Henderson  would  have been  entitled  to receive  under his  then-existing
termination  compensation agreement with the Company. Mr. Henderson will provide
executive  duties,  services and functions,  provide advice and counsel and have
executive  responsibilities  and authority as specifically  assigned to him from
time to time during the consulting  period by the President and Chief  Executive
Officer of the Company.

Note 10. - Commitments
- ----------------------

     The Company has been working with a software development company to upgrade
the current  operating  platform and the Company's  general ledger software.  To
date, the Company has spent  approximately  $1.2 million in developing  programs
and defining functional requirements. Upon review of the functional requirements
the Company  determined  that the scope of the project had expanded and the cost
commitment  would  substantially  increase from the original  commitment of $2.5
million to approximately $3.7 million.  Due to the substantial increase in cost,
the Company has placed a hold on further  development and implementation of this
project to fully re-evaluate potential benefits and cost savings.

Item 2. -  Management's  Discussion  and  Analysis of  Financial  Condition  and
- --------------------------------------------------------------------------------
Results of Operations
- ---------------------

     This Quarterly Report on Form 10-Q contains forward-looking statements that
are made  pursuant  to the safe  harbor  provisions  of the  Private  Securities
Litigation  Reform Act of 1995.  Forward-looking  statements  involve  known and
unknown risks and  uncertainties  that may cause the Company's actual results in
future periods to differ  materially  from forecasted  results.  These risks and
uncertainties  may include,  but are not limited to, the cost, effect and timing
of restructuring  activities that have been commenced,  including our ability to
achieve and sustain the annual expense  reductions  anticipated;  the timing and
rate of the resumed growth in the staffing  division;  changes in and compliance
with governmental  reimbursement  rates;  regulations or policies  affecting the
hospital rehabilitation  services and contract therapy divisions,  including the
Company's estimates with respect to the effect of newly promulgated  regulations
on  the  Company's  business;  the  Company's  ability  to  attract  new  client
relationships  or to retain and grow existing client  relationships  through the
integration  of our new  information  system  with those of our  clients and the
development  of  alternative  product  offerings;  our ability to  identify  and
consummate, within the expected time frame, strategic acquisitions to accelerate
growth in the Company's  divisions;  the Company's  ability,  and the additional
costs, to attract operational and professional employees;  significant increases
in  health,   worker's  compensation  and  professional  and  general  liability
insurance   premiums;   the  adequacy  and   effectiveness   of  operating   and
administrative  systems;  litigation  risks,  including the Company's ability to
predict the ultimate  costs and  liabilities  or the disruption of the Company's
operations;  competitive  and  regulatory  effects on pricing and  margins;  and
general economic  conditions,  including  efforts by governmental  reimbursement
programs, insurers, healthcare providers and others to contain healthcare costs.

                                    14 of 26




REHABCARE GROUP, INC.

Item 2. -  Management's  Discussion  and  Analysis of  Financial  Condition  and
- --------------------------------------------------------------------------------
Results of Operations (Continued)
- ---------------------------------

Results of Operations
- ---------------------

     The  Company  derives  its  revenue  from two  business  segments:  program
management  services for hospitals and skilled nursing facilities and healthcare
staffing  services.  The Company's program  management segment includes hospital
rehabilitation  services  (including  inpatient  acute  rehabilitation,  skilled
nursing units and outpatient  therapy  programs) and contract therapy  programs.
The Company's  healthcare staffing segment includes both supplemental  personnel
and traveling  personnel  who are  typically  placed based on hourly and 13-week
assignments, respectively.


Selected Operating Statistics:
                                       Three Months Ended      Nine Months Ended
                                         September 30,           September 30,
                                        2003        2002        2003      2002
                                        ----        ----        ----      ----
Hospital Rehabilitation Services
- --------------------------------
                                                           
Operating Revenues (in thousands)
  Inpatient                          $ 34,161    $ 33,113   $ 102,076  $ 96,939
  Outpatient                           12,342      12,097      36,899    36,849
                                      -------     -------      ------    ------
  Total                              $ 46,503    $ 45,210   $ 138,975 $ 133,788
Average Number of Programs
  Inpatient                               133         137         135       135
  Outpatient                               48          55          49        55
                                          ---         ---         ---       ---
  Total                                   181         192         184       190
Inpatient Patient Days                179,110     185,775     544,046   556,996
Outpatient Visits                     313,004     332,628     953,058 1,036,189

Contract Therapy
Operating Revenues (in thousands)    $ 33,607    $ 27,223    $ 97,447  $ 76,245
Average Number of Locations               473         396         453       369
Average Revenue per Location         $ 71,094    $ 68,674    $215,113  $206,428


                                    15 of 26



REHABCARE GROUP, INC.

Operating Statistics: (Continued)
- ---------------------------------


                                     Three Months Ended       Nine Months Ended
                                        September 30,           September 30,
                                      2003        2002          2003      2002
                                      ----        ----          ----      ----
Healthcare Staffing
- -------------------
                                                          
Operating Revenues (in thousands)
  Supplemental                     $ 29,605    $ 42,827    $ 97,500   $ 133,195
  Travel                             25,586      27,430      77,001      78,527
                                    -------     -------     -------     -------
  Total*                           $ 55,191    $ 70,257    $174,501    $211,722

Gross Profit Margin
  Supplemental                         18.5%       23.9%       19.8%       23.4%
  Travel                               16.0%       21.9%       18.3%       21.6%
  Total                                17.3%       23.1%       19.1%       22.7%

Weeks Worked
  Supplemental                       21,434      31,315      69,953     100,507
  Travel                             13,140      13,941      39,336      40,244
                                     ------      ------      ------      ------
  Total                              34,574      45,256     109,289     140,751

Average Number of
  Supplemental branches                  70         106          76         110


* Includes  intercompany  revenues of $0.3  million  and $1.1  million at market
rates from the Company's  healthcare  staffing segment to the Company's  program
management  segment during the three months and nine months ended  September 30,
2003, respectively.


Three Months Ended  September 30, 2003 Compared to Three Months Ended  September
- --------------------------------------------------------------------------------
30, 2002
- --------

Operating Revenues

     Operating  revenues  during  the third  quarter of 2003  decreased  by $7.7
million,  or 5.4%,  to $135.0  million  compared to $142.7  million in the third
quarter of 2002.  Revenue  decreases in  supplemental  and travel  staffing were
partially  offset  by  revenue   increases  in  contract  therapy  and  hospital
rehabilitation services.

     Hospital rehabilitation services revenues, consisting of hospital inpatient
and outpatient programs,  increased by $1.3 million, or 2.9%, from $45.2 million
in the third  quarter  of 2002 to $46.5  million  in the third  quarter of 2003.
Inpatient revenues increased by $1.1 million, or 3.2%, from $33.1 million in the
third quarter of 2002 to $34.2 million in the third quarter of 2003 primarily as
a result of a 5.9%  increase in average  revenue per  program.  The  increase in
average revenue per program  primarily  resulted from contract  modifications to
align the fee structure with the recently implemented prospective payment system
for  rehabilitation  facilities.  Outpatient  revenues increased by $0.2 million
from $12.1  million in the third  quarter of 2002 to $12.3  million in the third
quarter  of 2003,  with a 12.4%  decrease  in the  average  number  of  programs
operated,  offset by a 16.5%  increase  in the average  revenue  per  outpatient
program.

                                    16 of 26



REHABCARE GROUP, INC.

Three Months Ended  September 30, 2003 Compared to Three Months Ended  September
- --------------------------------------------------------------------------------
30, 2002 (Continued)
- --------------------

     Contract  therapy  revenues  increased  by 23.5% from $27.2  million in the
third quarter of 2002 to $33.6  million in the third quarter of 2003,  primarily
reflecting  a 19.2%  increase  in the  average  number of  locations  and a 3.5%
increase  in the  average  revenue  per  location.  The  increase in the average
revenue  per  location  is  primarily  the  result of same  store  growth  and a
continued focus on opening larger locations.

     Healthcare  staffing  revenues  decreased  from $70.3  million in the third
quarter of 2002 to $55.2  million in the third  quarter of  2003(including  $0.3
million  inter-company sales at market rates to the Company's program management
segment).  Supplemental  staffing revenues decreased by $13.2 million, or 30.9%,
to $29.6 million in the third quarter of 2003,  reflecting the  consolidation of
branch  locations  in the first  quarter of 2003 and a decline in the demand for
staffing agency services.  The average number of branch locations decreased from
106 in the  third  quarter  of 2002 to 70 in the  third  quarter  of  2003.  The
decrease in supplemental  staffing  revenues is attributable to a 31.6% decrease
in weeks  worked as a result of the  consolidation  of  branch  locations  and a
decline in demand, offset by a 1.0% increase in average revenue per week worked.
The  increase in average  revenue  per week worked was a result of placing  more
highly  credentialed  staff such as  registered  nurses as compared to certified
nurse  assistants,  as well as  increased  bill  rates for the  certified  nurse
assistants. Travel staffing revenues decreased by 6.7% from $27.4 million in the
third  quarter of 2002 to $25.6  million  in the third  quarter of 2003 as weeks
worked and revenue per week worked  decreased 5.7% and 1.0%,  respectively.  The
decline in weeks worked was driven by a decrease in demand for  travelers  while
the  decrease  in  revenue  per week is a result of a  decrease  in  radiologist
average bill rates and a shift in sales mix to more radiologists.

Cost and Expenses

     Operating  expenses  (excluding  provision  for  doubtful  accounts)  as  a
percentage of operating  revenues  increased  from 72.1% in the third quarter of
2002  to  75.9%  in the  third  quarter  of  2003,  primarily  reflecting  lower
productivity  in the contract  therapy  division due to a now completed  complex
information  system conversion during the third quarter 2003 and increased labor
and benefit costs in all  divisions.  The  provision for doubtful  accounts as a
percentage  of operating  revenues  increased  from 0.7% in the third quarter of
2002 to 0.8% in the third  quarter of 2003 as the Company  adjusted  its accrual
rates to reflect  changes in  accounts  receivable  agings and recent  write-off
experience.   Division  selling,   general  and  administrative  expenses  as  a
percentage of operating  revenues  decreased  from 13.0% in the third quarter of
2002 to 11.7% in the  third  quarter  of 2003  primarily  due to  reductions  in
contract therapy, the outpatient division of hospital  rehabilitation  services,
and  supplemental  staffing.   Corporate  selling,  general  and  administrative
expenses as a percentage of revenues increased from 4.5% in the third quarter of
2002 to 4.9% in the third quarter of 2003  primarily  reflecting a lower revenue
base and  increases in  consulting  costs as a result of the  arrangements  with
Phase 2 and Alan C.  Henderson,  both entered into in the second  quarter  2003.
Depreciation  and  amortization  expense as a percent of operating  revenues was
comparable for each period.

     In  the  hospital  rehabilitation  services  division,  operating  expenses
(excluding  provision for doubtful accounts) increased by 4.2%, or $1.2 million,
primarily  reflecting  increased  salary-related  expenses in both inpatient and
outpatient  divisions as a result of higher workers  compensation,  professional
liability and health insurance expenses.  The  provision  for doubtful  accounts

                                    17 of 26



REHABCARE GROUP, INC.

Three Months Ended  September 30, 2003 Compared to Three Months Ended  September
- --------------------------------------------------------------------------------
30, 2002 (Continued)
- --------------------

as a percentage of operating revenues increased from 0.2% to 0.5%,  primarily as
a result of the  normal  evaluation  of the  creditworthiness  of the  Company's
clients.  Selling,  general and  administrative  expenses for this division as a
percentage of operating revenues declined from 8.4% in the third quarter of 2002
to 7.9% in the third  quarter  of 2003.  Corporate  general  and  administrative
expenses,  which represent  allocations of corporate  office expenses based upon
utilization  by  divisions,  increased  for  the  division  as a  percentage  of
operating revenues from 3.9% to 4.7%. Depreciation and amortization expense as a
percentage  of operating  revenues  decreased  from 3.2% in the third quarter of
2002 to 2.7% in the third  quarter  of 2003,  reflecting  a change in the useful
life of a software system from 3 years to 5 years in the second quarter of 2003.
Operating  earnings (earnings before interest and income taxes) in this division
decreased  slightly  from  $8.8  million  in the third  quarter  of 2002 to $8.6
million in the third quarter of 2003.

     In the contract therapy division,  operating expenses (excluding  provision
for doubtful accounts) increased by 35.8%, or $7.0 million,  primarily due to an
increase  in  contract  labor  and  salary-related  expenses,  as well as  lower
productivity  as  a  result  of  a  now  completed  complex  information  system
conversion during the third quarter 2003. The provision for doubtful accounts as
a percentage  of operating  revenues was  comparable  for each period.  Division
selling,  general and  administrative  expenses  as a  percentage  of  operating
revenues  decreased  from 9.9% in the third quarter of 2002 to 9.2% in the third
quarter  of 2003,  primarily  as a result of  revenues  increasing  faster  than
selling,   general   and   administrative   expenses.   Corporate   general  and
administrative   expenses,  which  represent  allocations  of  corporate  office
expenses based upon  utilization  by divisions,  increased for the division as a
percentage  of  operating   revenues  from  5.9%  to  6.2%.   Depreciation   and
amortization  expense as a percentage of operating  revenues decreased from 1.1%
in the third quarter 2002 to 1.0% in the third quarter 2003.  Operating earnings
(earnings  before interest and income taxes) in this division  decreased by $1.7
million, or 64.6%, to $0.9 million.

     In the  staffing  segment,  operating  expenses  (excluding  provision  for
doubtful  accounts)  decreased 15.5%, or $8.4 million,  due to lower volumes and
increases in certain  categories of operating  expense.  Gross profit margins in
the supplemental  staffing division decreased from 23.9% in the third quarter of
2002 to 18.5% in the third  quarter of 2003,  while gross profit  margins in the
travel division also decreased in the third quarter of 2003 to 16.0% compared to
21.9% in the  comparable  quarter last year. The decrease in gross profit margin
in the supplemental  staffing  division was primarily the result of increases in
workers  compensation,  professional and general liability and medical insurance
claims  cost.  The decrease in gross profit  margin  within the travel  staffing
division  was a result of changes  within  staff  incentives  and  increases  in
salary-related  expenses.  The provision for doubtful  accounts  decreased  $0.1
million in the third  quarter  of 2003  compared  to the third  quarter of 2002,
primarily as a result of the normal  evaluation of the  creditworthiness  of the
Company's  clients  showing  improvement  as  supported  by the  improvement  in
accounts  receivable aging over the same period.  Division selling,  general and
administrative expenses decreased by $3.1 million or 25.3% as a result of branch
consolidations  in the first  quarter of 2003 and  decreases  in  administrative
personnel.  This resulted in a decrease in selling,  general and  administrative
expenses as a percentage  of operating  revenues from 17.2% in the third quarter
of  2002  to  16.3%  in  the  third  quarter  of  2003.  Corporate  general  and
administrative   expenses,  which  represent  allocations  of  corporate  office
expenses based upon  utilization  by divisions,  decreased for the division as a
percentage  of  operating   revenues  from  4.4%  to  4.1%.   Depreciation   and
amortization  expenses as a percentage of operating revenues increased from 0.6%

                                    18 of 26




REHABCARE GROUP, INC.

Three Months Ended  September 30, 2003 Compared to Three Months Ended  September
- --------------------------------------------------------------------------------
30, 2002 (Continued)
- --------------------

in the third quarter of 2002 to 0.9% in the third quarter of 2003, primarily due
to  comparable  expense on less revenue.  Operating  earnings  (earnings  before
interest and income taxes) in the staffing group  decreased by $2.8 million from
operating  earnings of $0.2 million in the third quarter of 2002 to an operating
loss of $2.6 million in the third quarter of 2003.

     The  restructuring  charge  represents  severance  and  outplacement  costs
associated  with  the  reduction  in  force  of 61  positions  as well as  costs
associated with closing five supplemental staffing branch offices. See Note 6. -
"Restructuring Costs" to the condensed consolidated financial statements.

Non-operating Items

      Interest income was comparable for both periods.

     Interest expense  primarily  represents  commitment fees paid on the unused
portion of the line of credit and letter of credit fees and was  comparable  for
both periods. The Company had no outstanding balance on the line of credit as of
September 30, 2003 and September 30,2002.

     Earnings  before  income  taxes  decreased  by 51.9% to $5.5 million in the
third  quarter of 2003 from  $11.5  million  in the third  quarter of 2002.  The
provision  for  income  taxes  was $2.2  million  in the third  quarter  of 2003
compared to $4.4  million in the third  quarter of 2002  representing  effective
income  tax rates of 40.0%  and  38.0%,  respectively.  The  effective  tax rate
increase was primarily a result of increased  non-deductible  meals  provided to
traveling  radiologists  and nurses in relation to earnings before income taxes.
Net earnings in the third quarter of 2003  decreased to $3.3 million as compared
to $7.1  million in the third  quarter of 2002.  Diluted net  earnings per share
decreased by 50.9% from $0.41 in the third quarter of 2002 to $0.20 in the third
quarter of 2003. A 5.2% decrease in the weighted-average  shares outstanding was
attributable  primarily to the  repurchase of 1.7 million shares of common stock
during the third quarter of 2002 and a smaller  dilutive effect of stock options
resulting from a lower average stock price in the third quarter 2003.

Nine Months Ended September 30, 2003 Compared to Nine Months Ended September 30,
- --------------------------------------------------------------------------------
2002
- ----

Operating Revenues

     Operating  revenues during the first nine months of 2003 decreased by $11.9
million, or 2.8%, to $409.8 million compared to $421.8 million in the first nine
months of 2002.  Revenue  decreases in  supplemental  and travel  staffing  were
partially  offset  by  revenue   increases  in  contract  therapy  and  hospital
rehabilitation services.

     Hospital rehabilitation services revenues, consisting of hospital inpatient
and outpatient programs,  increased by $5.2 million, or 3.9% from $133.8 million
in the first nine  months of 2002 to $139.0  million in the first nine months of
2003.  Inpatient revenues increased by $5.1 million, or 5.3%, from $96.9 million
in the first nine  months of 2002 to $102.1  million in the first nine months of
2003 as a result of a 5.4% increase in revenue per program on the same number of
average programs.  Outpatient  revenues remained flat from the first nine months
of 2002 to the first  nine  months of 2003, reflecting  an 11.4% decrease in the

                                    19 of 26



REHABCARE GROUP, INC.

Nine Months Ended September 30, 2003 Compared to Nine Months Ended September 30,
- --------------------------------------------------------------------------------
2002 (Continued)
- ----------------

the  average  number of  programs  operated,  offset by a 13.0%  increase in the
average revenue per outpatient program.

     Contract  therapy  revenues  increased  by 27.8% from $76.2  million in the
first nine  months of 2002 to $97.4  million  in the first nine  months of 2003,
primarily  reflecting a 22.6%  increase in the average number of locations and a
4.2% increase in the average  revenue per location.  The increase in the average
revenue  per  location  is  primarily  the  result of same  store  growth  and a
continued focus on opening larger locations.

     Healthcare  staffing  revenues  decreased  from $211.7 million in the first
nine months of 2002 to $174.5 million in the first nine months of 2003(including
$1.1  million  inter-company  sales at  market  rates to the  Company's  program
management segment).  Supplemental staffing revenues decreased by $35.7 million,
or 26.8%,  from $133.2 million in the first nine months of 2002 to $97.5 million
in the  first  nine  months  of 2003,  reflecting  the  consolidation  of branch
locations in the first  quarter of 2003 and a decline in the demand for staffing
agency services.  The average number of branch  locations  decreased from 110 in
the  first  nine  months  of 2002 to 76 in the first  nine  months of 2003.  The
decrease in supplemental  staffing  revenues is attributable to a 30.4% decrease
in weeks  worked as a result of the  consolidation  of  branch  locations  and a
decline in demand,  partially  offset by a 5.2% increase in average  revenue per
week  worked.  The  increase  in revenue per week worked was a result of placing
more  highly  credentialed  staff  such as  registered  nurses  as  compared  to
certified  nurse  assistants.  Travel staffing  revenues  decreased by 1.9% from
$78.5  million  in the first nine  months of 2002 to $77.0  million in the first
nine months of 2003  primarily  due to a 2.3% decrease in weeks worked as demand
slowed, partially offset by a 0.3% increase in revenue per week worked.

Cost and Expenses

     Operating  expenses  (excluding  provision  for  doubtful  accounts)  as  a
percentage of operating  revenues  increased from 72.8% in the first nine months
of 2002 to 75.1% in the first  nine  months of 2003,  primarily  reflecting  the
continued  migration  of the skill mix in our  staffing  division to more highly
credentialed professionals,  lower productivity in the contract therapy division
due to a now completed  complex  information  system conversion during the third
quarter  2003 and  increased  labor  and  benefit  costs in all  divisions.  The
provision for doubtful accounts as a percentage of operating  revenues decreased
from 0.8% in the prior year nine month  period to 0.7% in the current nine month
period due to the improvement in the aging categories of the Company's  accounts
receivables during the first and second quarters.  Division selling, general and
administrative  expenses as a percentage of operating  revenues  decreased  from
13.4% in the first nine months of 2002 to 12.5% in the first nine months of 2003
primarily due to reductions in contract  therapy and the outpatient  division of
hospital rehabilitation services, partially offset by increases in the inpatient
division of hospital  rehabilitation  services and staffing.  Corporate selling,
general and administrative  expenses as a percentage of revenues were comparable
each of the nine  month  periods as  restructuring  and cost  reduction  efforts
maintained   costs  in  relation  to  decreased   revenues.   Depreciation   and
amortization  expense as a percent of operating  revenues increased to 1.6% from
1.5% due to depreciation expense recorded on additional capital expenditures.

     In  the  hospital  rehabilitation  services  division,  operating  expenses
(excluding  provision for doubtful accounts) increased by 4.6%, or $4.0 million,
primarily  reflecting  increased  salary-related  expenses in both inpatient and
outpatient  divisions as a result of higher workers  compensation,  professional
liability and health insurance expenses.  The  provision  for doubtful  accounts

                                    20 of 26



REHABCARE GROUP, INC.

Nine Months Ended September 30, 2003 Compared to Nine Months Ended September 30,
- --------------------------------------------------------------------------------
2002 (Continued)
- ----------------

as a percentage  of  operating  revenues  increased  from 0.2% in the first nine
months of 2002 to 0.4% in the first nine months of 2003,  primarily  as a result
of the normal  evaluation  of the  creditworthiness  of the  Company's  clients.
Selling,  general and  administrative  expenses for this division decreased as a
percentage  of operating  revenues  from 9.0% to 8.7%,  largely due to synergies
achieved in integrating  inpatient and outpatient  into one division.  Corporate
general and administrative  expenses,  which represent  allocations of corporate
office expenses based upon utilization by divisions,  increased for the division
as a  percentage  of  operating  revenues  from 4.5% to 4.7%.  Depreciation  and
amortization  expense as a percentage of operating  revenues decreased from 3.0%
in the  first  nine  months of 2002 to 2.9% in the  first  nine  months of 2003.
Operating  earnings (earnings before interest and income taxes) in this division
increased  from $23.2  million in the first nine months of 2002 to $23.7 million
in the first nine months of 2003.

     In the contract therapy division,  operating expenses (excluding  provision
for doubtful  accounts)  increased by 36.4%, or $20.2 million,  primarily due to
higher wage and salary-related expenses for therapists,  a greater use of higher
cost  contract  labor,  and lower  productivity  in the third  quarter 2003 as a
result of a now completed complex  information system conversion.  The provision
for doubtful  accounts as a percentage of operating  revenues was comparable for
each  period.  Division  selling,  general  and  administrative  expenses  as  a
percentage of operating  revenues  decreased from 10.2% in the first nine months
of 2002 to 9.2% in the  first  nine  months  of 2003,  primarily  as a result of
revenues  increasing faster than selling,  general and administrative  expenses.
Corporate general and administrative  expenses,  which represent  allocations of
corporate  office expenses based upon  utilization by divisions,  also decreased
for the  division  as a  percentage  of  operating  revenues  from 6.4% to 6.2%.
Depreciation and amortization  expense as a percentage of operating revenues was
comparable for the two periods. Operating earnings (earnings before interest and
income taxes) in this  division  decreased by $1.8  million,  or 28.4%,  to $4.5
million.

     In the  staffing  segment,  operating  expenses  (excluding  provision  for
doubtful accounts)  decreased 13.7%, or $22.5 million,  due to lower volumes and
increases in certain  categories of operating  expense.  Gross profit margins in
the supplemental staffing division decreased from 23.4% in the first nine months
of 2002 to 19.8% in the first nine months of 2003, while gross profit margins in
the travel  division  also  decreased  in the first nine months of 2003 to 18.3%
compared to 21.6% in the comparable  nine months last year.  These  decreases in
gross  profit  margins  are  primarily  the result of  increased  salary-related
expenses and changes within the travel division staff incentives.  The provision
for doubtful accounts decreased by $1.1 million in the first nine months of 2003
compared to the first nine months of 2003,  primarily  as a result of the normal
evaluation of the  creditworthiness of the Company's clients showing improvement
as supported by the improvement in accounts receivable aging.  Division selling,
general and administrative  expenses  decreased $6.4 million,  thus resulting in
comparable  expenses as a  percentage  of  operating  revenues of 17.3% for both
periods.   Corporate  general  and  administrative   expenses,  which  represent
allocations of corporate  office  expenses based upon  utilization by divisions,
decreased  for the division as a percentage  of operating  revenues from 4.8% in
the  first  nine  months  of 2002 to 4.5% in the  first  nine  months  of  2003.
Depreciation  and  amortization  expenses as a percentage of operating  revenues
increased  from 0.6% in the first nine  months of 2002 to 0.8% in the first nine
months of 2003 as costs remained approximately the same on a lower revenue base.
Operating  earnings  (earnings before interest and income taxes) in the staffing
group  decreased  by $4.9  million from a loss of $1.8 million in the first nine
months of 2002 to a loss of $6.7 million.

                                    21 of 26



REHABCARE GROUP, INC.

Nine Months Ended September 30, 2003 Compared to Nine Months Ended September 30,
- --------------------------------------------------------------------------------
2002 (Continued)
- ----------------

     The  restructuring  charge  represents  severance  and  outplacement  costs
associated  with  the  reduction  in  force  of 61  positions  as well as  costs
associated with closing five supplemental staffing branch offices. See Note 6. -
"Restructuring Costs" to the Condensed Consolidated Financial Statement.

Non-operating Items

     Interest  income  decreased by $0.2 million when  comparing  the first nine
months of 2003 to the first nine months of 2002 as a result of decreased average
cash balances and interest rates.

     Interest expense  primarily  represents  commitment fees paid on the unused
portion  of the line of  credit  and  letter  of credit  fees.  For the  periods
compared,  this expense  increased  slightly as a result of increased letters of
credit.  The  Company  had no  outstanding  balance  on the line of credit as of
September 30, 2003 and September 30, 2002.

     Earnings  before  income taxes  decreased by 28.6% to $19.6  million in the
first nine  months of 2003 from $27.5  million in the first nine months of 2002.
The provision for income taxes was $7.8 million in the first nine months of 2003
compared  to  $10.4  million  in the  first  nine  months  of 2002  representing
effective income tax rates of 39.8% and 38.0%,  respectively.  The effective tax
rate increase was largely the result of increased  non-deductible meals provided
to  traveling  radiologists  and nurses in relation to  earnings  before  income
taxes.  Net earnings in the first nine months of 2003 decreased to $11.8 million
as compared to $17.0 million the first nine months of 2002. Diluted net earnings
per share  decreased  by 24.3% from  $0.95 in the first  nine  months of 2002 to
$0.72 in the first nine months of 2003. An 8.3% decrease in the weighted-average
shares  outstanding was attributable  primarily to the repurchase of 1.7 million
shares of common stock during the third  quarter of 2002 and a smaller  dilutive
effect of stock options resulting from a lower average stock price.

Regulatory Impact

     The Medicare proposed "65 Percent Rule" is not expected to impact operating
results in 2003,  as the final rule is not  expected to be released  until early
December  2003,  with  implementation  no sooner  than early  2004.  The Company
typically does not make specific  comments on the impact of proposed  rulemaking
or  legislation  prior  to  final  effectiveness  as the  impact  often  changes
significantly during the approval process.  However, given the advanced stage of
this proposed rule and the evaluation of the potential  impact  completed by the
Company,  the rule's  impact is  expected to result in an  estimated  decline in
discharges of zero to 3 percent in 2004 in our hospital  rehabilitation services
division due to differing  cost  reporting  periods.  Mitigation  strategies  to
replace  utilization  through enhanced internal and external census  development
would result in the decline in  discharges  being at the lower end of the range.
While the rule primarily affects the hospital  rehabilitation services division,
the Company expects that the contract therapy division will potentially benefit,
as patients that cannot be served in the acute rehab setting may receive therapy
in the nursing home setting.

                                    22 of 26



REHABCARE GROUP, INC.

Nine Months Ended September 30, 2003 Compared to Nine Months Ended September 30,
- --------------------------------------------------------------------------------
2002 (Continued)
- ----------------

     On September 1, 2003,  the Medicare  Part B therapy caps became  effective,
which provide for a cap of $1,590 on certain Part B therapy services. These caps
will impact the Company's  contract  therapy  division  through the remainder of
2003.  The  division  has been able to  mitigate  some of the impact of the caps
through  therapy  productivity  improvements.  However,  because the caps may be
short-term  in duration,  the  division  has elected not to make more  permanent
changes to its operating model.

Liquidity and Capital Resources

     As of September 30, 2003,  the Company  reported  $27.4 million in cash and
current marketable  securities and a current ratio, the amount of current assets
divided by current liabilities,  of 3.1 to 1. Working capital increased by $18.9
million to $86.8  million as of September  30, 2003 as compared to $67.8 million
as of December  31, 2002 due to an increase in current  assets of $23.4  million
combined with an increase in current  liabilities of $4.5 million.  The increase
in current  assets was primarily  due to increased  cash balances as a result of
cash  generated  from  operations  and an increase in  accounts  receivable  and
deferred tax assets. Net accounts receivable were $90.6 million at September 30,
2003,  compared  to $87.2  million at  December  31,  2002.  The number of days'
average net revenue in net  receivables  was 61.8 and 57.7 at September 30, 2003
and  December 31,  2002,  respectively.  The increase in deferred tax assets was
primarily due to an increase in accrued vacation,  accrued workers compensation,
professional  liability insurance and health insurance.  The decrease in capital
expenditures  in the current  year as compared to the prior year was a result of
the completion of major system  enhancements  and  implementations  last year to
support  the  clinical  operations  of the  Company.  The  increase  in  current
liabilities was primarily the result of an increase in health insurance accruals
and workers compensation and professional liability accruals and expenses offset
by a decrease in accounts payable and accrued salaries and wages.

     The Company's  operating cash flows constitute the Company's primary source
of liquidity and  historically  have been  sufficient  to fund working  capital,
capital expenditures, internal business expansion and debt service requirements.
The Company expects to meet its future working  capital,  capital  expenditures,
internal and external  business  expansion and debt service  requirements from a
combination of internal sources and outside financing.  The Company has a $125.0
million revolving line of credit with no balance outstanding as of September 30,
2003.  The Company  has $6.2  million in letters of credit  issued to  insurance
carriers as collateral for reimbursement of claims. The letters of credit reduce
the amount the Company may borrow under the line of credit. The Company also has
a $7.6 million  promissory  note issued to the  Company's  workers  compensation
carrier as  additional  collateral.  The  promissory  note is not  recorded as a
liability on the balance sheet as it would only become  payable upon an event of
default as defined  in the  security  agreement  with the  workers  compensation
carrier.

Item 3. - Quantitative and Qualitative Disclosures About Market Risks
- ---------------------------------------------------------------------

      There have been no material changes in the reported market risks since the
filing of the Company's Annual Report on Form 10-K for the year ended December
31, 2002.

Item 4. - Controls and Procedures
- ---------------------------------

     As of September 30, 2003, the Company's Interim Chief Executive Officer and
Chief Financial Officer have conducted an evaluation of the effectiveness of the
design and operation of the Company's  disclosure  controls and  procedures  (as
defined in Rule 13a-15 (e) and 15d-15 (e) under the  Securities  Exchange Act of
1934,  as  amended).  Based on that  evaluation,  the  Company's  Interim  Chief


                                    23 of 26



REHABCARE GROUP, INC.

Nine Months Ended September 30, 2003 Compared to Nine Months Ended September 30,
- --------------------------------------------------------------------------------
2002 (Continued)
- ----------------

Executive  Officer and Chief Financial Officer have concluded that the Company's
disclosure  controls and  procedures  are  effective in making known in a timely
fashion  material  information  required to be filed in this report.  There have
been  no  changes  in  internal  control  over  financial  reporting  that  have
materially  affected,  or  are  reasonably  likely  to  materially  affect,  the
Company's internal control over financial reporting.

Part II. - Other Information
- ----------------------------

Item 1 - Legal Proceedings
- --------------------------

     The Company is subject to various  claims and legal actions in the ordinary
course of business.  These matters  include,  without  limitation,  professional
liability  and  employee-related  matters and inquiries  and  investigations  by
governmental  agencies relating to Medicare or Medicaid  reimbursement and other
issues.

     In May 2002,  the Company  was named as a defendant  in a suit filed in the
United  States  District  Court for the Eastern  District  of Missouri  alleging
violations of the federal  securities  laws and seeking to certify the suit as a
class  action.  Certain  current  and former  officers  of the  Company are also
defendants  in the suit and are being  jointly  defended  with the Company.  The
proposed class consists of persons who purchased  shares of the Company's common
stock  between  August 10, 2000 and January 21, 2002.  The  plaintiffs  filed an
amended complaint in December 2002 that focuses primarily on alleged  weaknesses
in the  software  system  selected  by the  Company's  Staffing  Group  and  the
purported  negative effects of such systems on the healthcare  staffing services
business  operations.  The Company's  director and officer  liability  insurance
carrier has preliminarily accepted coverage of the action, including the payment
of defense costs after the satisfaction of the Company's deductible,  subject to
the applicable limits of the policy.  The court recently issued an order denying
the  Company's  motion  to  dismiss,  without  prejudice,  while  directing  the
plaintiff to amend its complaint to present its claims with more  particularity.
The  Plaintiffs  filed an amended  complaint on November 7, 2003 and the Company
expects to file a new motion to dismiss in the near future.

     In August 2002,  each of the  Company's  directors was named as a defendant
and the Company was named as the nominal defendant in a derivative suit filed in
the Circuit Court of St. Louis County,  Missouri. The complaint,  which is based
upon similar events as are alleged in the federal  securities class action,  was
filed on behalf of the derivative plaintiff by a law firm that had earlier filed
suit  against  the Company in the federal  case.  The Company  filed a motion to
dismiss based primarily on the derivative plaintiff's failure to make a pre-suit
demand on the board,  which was denied. The federal court hearing the securities
law class action stayed  discovery in the derivative  proceeding until discovery
commences in the federal securities law class action.

     In February 2003,  the Company was named as a  co-defendant  in a complaint
filed in the United States District Court for the Northern  District of Illinois
seeking  investment-banking  fees under a retainer agreement executed by Maurice
Echales in February 1997 on behalf of eai Healthcare Staffing Solutions ("eai"),
a company that was acquired in December  1999. On October 30, 2003,  the parties
reached an agreement in principle  whereby the plaintiff will release all claims
arising out of the agreement and the investment banking relationship against Mr.
Echales, the Company and all of its subsidiaries and affiliates, in exchange for
a lump sum  payment to be paid by Mr.  Echales,  without  contribution  from the


                                    24 of 26



Item 1 - Legal Proceedings (Continued)
- --------------------------------------

Company.  Mr.  Echales has also agreed to reimburse the Company for its attorney
fees and expenses incurred in this matter.  The attorneys for the parties are in
the process of documenting a settlement agreement at this time.

     In July,  2003 a civil Qui Tam  action  was  filed  against  Baxter  County
Regional  Hospital,  Inc.  ("Baxter"),  and the  Company  in the  United  States
District Court for the Eastern  District of Arkansas,  seeking  treble  damages,
civil penalties, back pay, and special damages. The allegations contained in the
suit,  brought by a former  independent  contractor  of the Company and a former
Baxter physical therapist,  relate to the clinical diagnoses of patients treated
at the hospital's acute rehabilitation unit for Medicare reimbursement purposes.
The suit alleges that Baxter and the Company received reimbursement in excess of
$5,000,000.  The  original  action was filed on August  21,  2000,  under  seal,
requiring an  investigation  by the United  States  Department  of Justice.  The
Company and Baxter fully cooperated with the Department's  investigation  and on
June 3, 2003, after completion of the investigation,  the Department declined to
intervene  and the seal was lifted.  The Company  and Baxter also  initiated  an
internal and external  audit that concluded the  allegations  were unfounded and
that the Company and Baxter were in compliance  with Medicare  regulations.  The
relators filed an amended complaint,  and the Company was served and notified of
the civil  allegations  on July 15,  2003.  The Company has agreed to  indemnity
Baxter for certain  fees and expenses on all counts  except one,  arising out of
the action.  No  discovery  has been  commenced  in the case pending the court's
ruling on the defendant's motion to dismiss.

     The Wage and Hour  Division  of the United  States  Department  of Labor is
currently  investigating  whether  persons  employed as on call  coordinators at
certain  staffing  branch  locations  were  properly  compensated  for all hours
worked, and whether the entire time they were on call should be counted as hours
worked.  The Company has advised the Wage and Hour  Division that it believes on
call  coordinators  paid a flat  fee per  shift  were  properly  compensated  in
accordance  with  applicable  federal  law. The inquiry is limited to the period
from January 1, 2001 to the present. No final determination or position has been
taken by the Wage and Hour Division to date with respect to these matters.

Item 6 - Exhibits and Reports on Form 8-K
- -----------------------------------------

    (a)  Exhibits

             See exhibit index

    (b) Reports on Form 8-K

             The Company has filed the following Current Reports on Form 8-K
             during the period ended September 30, 2003:

            Filing Date       Description of Event
            -----------       --------------------

        July 30, 2003         Item 9.  Press release dated July 30, 2003,
                              announcing the Company's earnings for the second
                              quarter 2003

                              Item 9.  Script for a conference call held by the
                              Registrant on July 30, 2003

        September 3, 2003     Item 9.  Text of Investor Relations Presentation
                              in use beginning September 3, 2003



                                    25 of 26




                                    SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.



                                                   REHABCARE GROUP, INC.

November 12, 2003



                                          By: /s/           Vincent L. Germanese
                                                   -----------------------------
                                                            Vincent L. Germanese
                                          Senior Vice President, Chief Financial
                                                           Officer and Secretary

                                    26 of 26






EXHIBIT INDEX


3.1   Restated Certificate of Incorporation (filed as Exhibit 3.1 to the
      Registrant's Registration Statement on Form S-1, dated May 9, 1991
      [Registration No.
      33-40467], and incorporated herein by reference)

3.2   Certificate of Amendment of Certificate of Incorporation (filed as Exhibit
      3.1 to the Registrant's Quarterly Report on Form 10-Q for the quarter
      ended May 31, 1995 and incorporated herein by reference)

3.3   Amended and Restated Bylaws (filed as Exhibit 3.3 to the Registrant;
      Quarterly Report on Form 10-Q for the quarter ended September 30, 2002 and
      incorporated herein by reference)

4.1   Rights Agreement, dated August 28, 2002, by and between the Registrant and
      Computershare Trust Company, Inc. (filed as Exhibit 1 to the Registrant's
      Registration Statement on Form 8-A filed September 5, 2002 and
      incorporated herein by reference)

31.1  Certification by Interim Chief Executive Officer pursuant to Rule
      13a-14(a) under the Securities Exchange Act of 1934, as amended

31.2  Certification by Chief Financial Officer pursuant to Rule 13a-14(a) under
      the Securities Exchange Act of 1934, as amended

32.1  Certification of periodic financial report pursuant to Section 906 of the
      Sarbanes-Oxley Act of 2002, U.S.C. Section 1350

32.2  Certification of periodic financial report pursuant to Section 906 of the
      Sarbanes-Oxley Act of 2002, U.S.C. Section 1350


- -------------------------








                                                                    EXHIBIT 31.1
                                  CERTIFICATION

      I, John H. Short, certify that:

      1. I have reviewed this quarterly report on Form 10-Q of RehabCare Group,
         Inc.;
      2. Based on my knowledge, this report does not contain any untrue
         statement of a material fact or omit to state a material fact necessary
         to make the statements made, in light of the circumstances under which
         such statements were made, not misleading with respect to the period
         covered by this report;
      3. Based on my knowledge, the financial statements, and other financial
         information included in this report, fairly present in all material
         respects the financial condition, results of operations and cash flows
         of the registrant as of, and for, the periods presented in this report;
      4. The registrant's other certifying officers and I are responsible for
         establishing and maintaining disclosure controls and procedures (as
         defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
         registrant and have:
            (a)   Designed such disclosure controls and procedures, or caused
                  such disclosure controls and procedures to be designed under
                  our supervision, to ensure that material information relating
                  to the registrant, including its consolidated subsidiaries, is
                  made known to us by others within those entities, particularly
                  during the period in which this quarterly report is being
                  prepared;
            (b)   Evaluated the effectiveness of the registrant's disclosure
                  controls and procedures and presented in this report our
                  conclusions about the effectiveness of the disclosure controls
                  and procedures, as of the end of the period covered by this
                  quarterly report based on such evaluation; and
            (c)   Disclosed in this report any change in the registrant's
                  internal control over financial reporting that occurred during
                  the registrant's most recent fiscal quarter (the registrant's
                  fourth fiscal quarter in the case of an annual report) that
                  has materially affected, or is reasonably likely to materially
                  affect, the registrant's internal control over financial
                  reporting; and
      5. The registrant's other certifying officers and I have disclosed, based
         on our most recent evaluation of internal control over financial
         reporting, to the registrant's auditors and the audit committee of the
         registrant's board of directors (or persons performing the equivalent
         functions):
            (a)   All significant deficiencies and material weaknesses in the
                  design or operation of internal control over financial
                  reporting which are reasonably likely to adversely affect the
                  registrant's ability to record, process, summarize and report
                  financial information; and
            (b)   Any fraud, whether or not material, that involves management
                  or other employees who have a significant role in the
                  registrant's internal control over financial reporting.



Date:  November 12, 2003


                                    By: /s/  John H. Short
                                        --------------------------
                                             John H. Short
                                          Interim President and
                                          Chief Executive Officer
                                          RehabCare Group, Inc.






                                                                    EXHIBIT 31.2
                                  CERTIFICATION

      I, Vincent L. Germanese, certify that:

      1. I have reviewed this quarterly report on Form 10-Q of RehabCare Group,
         Inc.;
      2. Based on my knowledge, this report does not contain any untrue
         statement of a material fact or omit to state a material fact necessary
         to make the statements made, in light of the circumstances under which
         such statements were made, not misleading with respect to the period
         covered by this report;
      3. Based on my knowledge, the financial statements, and other financial
         information included in this report, fairly present in all material
         respects the financial condition, results of operations and cash flows
         of the registrant as of, and for, the periods presented in this report;
      4. The registrant's other certifying officers and I are responsible for
         establishing and maintaining disclosure controls and procedures (as
         defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
         registrant and have:
            (a)   Designed such disclosure controls and procedures, or caused
                  such disclosure controls and procedures to be designed under
                  our supervision, to ensure that material information relating
                  to the registrant, including its consolidated subsidiaries, is
                  made known to us by others within those entities, particularly
                  during the period in which this quarterly report is being
                  prepared;
            (b)   Evaluated the effectiveness of the registrant's disclosure
                  controls and procedures and presented in this report our
                  conclusions about the effectiveness of the disclosure controls
                  and procedures, as of the end of the period covered by this
                  quarterly report based on such evaluation; and
            (c)   Disclosed in this report any change in the registrant's
                  internal control over financial reporting that occurred during
                  the registrant's most recent fiscal quarter (the registrant's
                  fourth fiscal quarter in the case of an annual report) that
                  has materially affected, or is reasonably likely to materially
                  affect, the registrant's internal control over financial
                  reporting; and
      5. The registrant's other certifying officers and I have disclosed, based
         on our most recent evaluation of internal control over financial
         reporting, to the registrant's auditors and the audit committee of the
         registrant's board of directors (or persons performing the equivalent
         functions):
            (a)   All significant deficiencies and material weaknesses in the
                  design or operation of internal control over financial
                  reporting which are reasonably likely to adversely affect the
                  registrant's ability to record, process, summarize and report
                  financial information; and
            (b)   Any fraud, whether or not material, that involves management
                  or other employees who have a significant role in the
                  registrant's internal control over financial reporting.



Date:  November 12, 2003


                                  By:  /s/  Vincent L. Germanese
                                       -------------------------
                                            Vincent L. Germanese
                                            Senior Vice President,
                                            Chief Financial Officer
                                            and Secretary
                                            RehabCare Group, Inc.





                                                                    Exhibit 32.1





                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of RehabCare Group, Inc. (the "Company")
on Form 10-Q for the period ending September 30, 2003 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, John H.
Short, Interim Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of
2002, that:


(1)   The Report fully complies with the requirements of section 13(a) or 15(d)
      of the Securities Exchange Act of 1934; and

(2)   The information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.



                                     By: /s/  John H. Short
                                        --------------------------
                                              John H. Short
                                          Interim President and
                                          Chief Executive Officer
                                          RehabCare Group, Inc.
                                          November 12, 2003



* A signed original of the written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to
the Securities and Exchange Commission or its staff upon request.







                                                                    Exhibit 32.2


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of RehabCare Group, Inc. (the "Company")
on Form 10-Q for the period ending September 30, 2003 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Vincent
L. Germanese, Senior Vice President Chief Financial Officer of the Company,
certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2002, that:


(1)   The Report fully complies with the requirements of section 13(a) or 15(d)
      of the Securities Exchange Act of 1934; and

(2)   The information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.



                                  By:  /s/  Vincent L. Germanese
                                       -------------------------
                                            Vincent L. Germanese
                                            Senior Vice President,
                                            Chief Financial Officer
                                            and Secretary
                                            RehabCare Group, Inc.
                                            November 12, 2003


* A signed original of the written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to
the Securities and Exchange Commission or its staff upon request.